American International Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-56,268
| Closed | -$1.33M | – | 3022 |
|
|
2023
Q4 | $1.33M | Buy |
56,268
+7,315
| +15% | +$130K | 0.01% | 1159 |
|
|
2023
Q3 | $730K | Buy |
48,953
+1,740
| +4% | +$23.1K | ﹤0.01% | 1394 |
|
|
2023
Q2 | $517K | Buy |
+47,213
| New | +$440K | ﹤0.01% | 1617 |
|
|
2022
Q2 | – | Sell |
-42,257
| Closed | -$131K | – | 3322 |
|
|
2022
Q1 | $131K | Buy |
42,257
+5,423
| +15% | +$17.1K | ﹤0.01% | 2477 |
|
|
2021
Q4 | $124K | Sell |
36,834
-1,102
| -3% | -$4.18K | ﹤0.01% | 2625 |
|
|
2021
Q3 | $138K | Sell |
37,936
-901
| -2% | -$3.55K | ﹤0.01% | 2648 |
|
|
2021
Q2 | $169K | Sell |
38,837
-1,535
| -4% | -$6.8K | ﹤0.01% | 2617 |
|
|
2021
Q1 | $183K | Buy |
40,372
+107
| +0.3% | +$576 | ﹤0.01% | 2417 |
|
|
2020
Q4 | $231K | Sell |
40,265
-1,155
| -3% | -$8.74K | ﹤0.01% | 2200 |
|
|
2020
Q3 | $300K | Sell |
41,420
-942
| -2% | -$5.04K | ﹤0.01% | 1888 |
|
|
2020
Q2 | $148K | Buy |
42,362
+1,585
| +4% | +$4.57K | ﹤0.01% | 2298 |
|
|
2020
Q1 | $60K | Sell |
40,777
-2,356
| -5% | -$3.96K | ﹤0.01% | 2595 |
|
|
2019
Q4 | $85K | Sell |
43,133
-364
| -0.8% | -$1.37K | ﹤0.01% | 2711 |
|
|
2019
Q3 | $223K | Sell |
43,497
-302
| -0.7% | -$1.83K | ﹤0.01% | 2104 |
|
|
2019
Q2 | $314K | Buy |
43,799
+5,794
| +15% | +$65.6K | ﹤0.01% | 1968 |
|
|
2019
Q1 | $505K | Sell |
38,005
-789
| -2% | -$8.39K | ﹤0.01% | 1701 |
|
|
2018
Q4 | $305K | Sell |
38,794
-299
| -0.8% | -$2.85K | ﹤0.01% | 1937 |
|
|
2018
Q3 | $433K | Buy |
39,093
+704
| +2% | +$8.74K | ﹤0.01% | 1976 |
|
|
2018
Q2 | $515K | Buy |
+38,389
| New | +$480K | ﹤0.01% | 1821 |
|
Other funds holding CBAY
American International Group's CBAY Position: Q1 2024 in Review
American International Group sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 56,268 shares — an estimated $1.33M sold.
American International Group first reported a position in CBAY in Q2 2018 and held it in 19 quarters. The position peaked at $1.33M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.
- American International Group reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
- American International Group sold 56,268 Cymabay Therapeutics shares in Q1 2024, an estimated $1.33M.
- American International Group first reported a position in Cymabay Therapeutics in Q2 2018 and held it in 19 quarters.
- American International Group's Cymabay Therapeutics position peaked at $1.33M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.
Based on American International Group's 13F filing for Q1 2024, filed 13 May 2024.